. Strong growth in total Group revenues to around EUR 980 million . Profit up to EUR 35.2 million . Proposed dividend EUR 0.50 per share . Positive outlook for 2007 financial year ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies/Consolidated financial statements Schrobenhausen, April 25, 2007 (euro adhoc) - The construction and equipment ...
Shanghai, China (ots/PRNewswire) - - Dodge brand officially enters Chinese market with first products revealed at Auto Shanghai 2007 - The best-selling Dodge Caravan will be locally produced in China for the Chinese market - Dodge Caliber will be the first imported Dodge vehicle available to customers in China - Portfolio of Dodge vehicles underlines the breadth and potential of the ...
San Jose, California (ots/PRNewswire) - - MAX-Link Solution Uses Impressive Integration Techniques to Support WiMAX Applications Atmel(R) Corporation (Nasdaq: ATML) announced today the second of its MAX-Link(TM) series of transceivers designed specifically for WiMAX applications. Along with enhanced WiMAX system functionality, the AT86RF535B enables one of the lowest component costs of any RF reference design ...
Barcelona, Spain (ots/PRNewswire) - - SEBIVO Suppressed Virus More Rapidly and Profoundly Than Adefovir(1) - Rapid and Powerful Viral Suppression Led to Better Treatment Outcomes(2) - SEBIVO Has Been Recommended for Approval by European Medicines Agency, Pending Final Approval by the European ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 22.03.2007 D i e t l i k o n, 22 March 2007. Born from the merger of the two most important Swiss construction enterprises, Zschokke and Batigroup, the Implenia Group, reports a successful ...
Bristol -Myers Squibb Company and Otsuka Pharmaceutical Co. Ltd
Madrid (ots/PRNewswire) - - New Survey Indicates There is Room for Improvement in Physical Health Management Strategies for People Living With Schizophrenia New data presented at the 15th European Congress of Psychiatry (AEP) indicates that the impact of weight gain and metabolic abnormalities associated ...
Carlsbad, California (ots/PRNewswire) - Micromet, Inc. (Nasdaq: MITI) ("Micromet" or the "Company"), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, today announced its financial results for the fourth quarter and the full year ended December 31, 2006. As a ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Company Information/share split 26.02.2007 PALFINGER Proposes Share Split Bergheim / Salzburg, February 26th, 2007 PALFINGER, the world market leader for truck-mounted knuckle-boom cranes, is proposing a 1:4 stock split for approval at its ...
London (ots/PRNewswire) - - Free Calls for Users of Nokia E and N Series Wi-Fi Mobile Phones Through barablu - Millions can Take Advantage as Wi-Fi Enabled Phones Become More Popular Nokia Wi-Fi enabled phones users can benefit from free phone calls between mobiles thanks to facilitator barablu. Nokia currently has nine Wi-Fi enabled models in the marketplace and their increasing popularity will see 100 ...
Prion proteins found in commercial milk Schlieren (ots) - In a first-time global breakthrough, a Swiss start-up firm has succeeded in detecting prion proteins in the milk of humans, cows, sheep, and goats. This again raises the question of a "mad cow disease" risk from drinking milk. Tests are underway to verify disease-causing prions in milk. Prions are known to be causes of neurological conditions such as Mad ...
Ingelheim, Germany (ots/PRNewswire) - Long-term data from the Nevirapine/Efavirenz/Abacavir (NEFA) study demonstrate that patients who switched from a protease inhibitor-based regimen to a non-nucleoside reverse transcriptase inhibitor-based regimen containing Viramune(R) (nevirapine) or efavirenz achieved comparable efficacy and safety to their previous regimen ...
San Diego (ots/PRNewswire) - - Revenues US$2.02 Billion, Diluted EPS US$0.38 - Pro Forma Revenues US$2.02 Billion, Diluted EPS US$0.43 - QUALCOMM Reaffirms Most Recent Fiscal 2007 Revenue and Pro Forma Earnings Guidance QUALCOMM Incorporated (Nasdaq: QCOM) today announced results for the first quarter of fiscal 2007 ended December 31, 2006. Total QUALCOMM (GAAP) First Quarter Results Total ...
Basel, Switzerland (ots/PRNewswire) - - New Phase III Data Presented at the American Society of Clinical Oncology Gastrointestinal Symposium (ASCO GI) continue to demonstrate the excellent efficacy of two of Roche's innovative cancer drugs Xeloda and Avastin, which offer improved survival for patients ...
Philadelphia, Pennsylvania (ots/PRNewswire) - - Study to Compare Immunogencity of GSK's Cervical Cancer Candidate Vaccine, CERVARIX(R), to Merck's Gardasil(R) GlaxoSmithKline (NYSE: GSK) announced today the initiation of the first study of its kind designed to compare the immunogenicity of its cervical cancer candidate vaccine, CERVARIX(R), versus ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 10.01.2007 U R G E N T: Invitation to a Press Conference on 11 Jan. 2007 at 11:00 a.m. Dear ladies and gentlemen, S&T AG will - subject to approval by the anti-trust authorities - acquire IMG ...
Alderley Park, England (ots/PRNewswire) - - For Non-US Healthcare Press Only AstraZeneca today announced RECENTIN(TM) as the global trademark for AZD2171, its oral, highly potent and selective vascular endothelial growth factor (VEGF) signalling inhibitor. AZD2171 is currently in Phase II/III development for advanced non-small cell lung cancer (NSCLC) and ...
San Diego (ots/PRNewswire) - QUALCOMM Incorporated (Nasdaq: QCOM) today updated its financial guidance for the first fiscal quarter ending December 31, 2006. The following statements are forward looking and actual results may differ materially. Please see "Note Regarding Forward-Looking Statements" at the end of this news release for a description of certain ...
Paris (ots/PRNewswire) - - New Data Presented at the 48th Annual Meeting and Exposition of the American Society of Hematology (ASH) For Non-US Journalists Only New data presented today showed that a substantial number of patients with chronic-phase chronic myelogenous leukaemia (CML) resistant to ...
Dublin, Ireland, November 29 (ots/PRNewswire) - Riverdeep Holdings Limited (the "Company") announced today that it has commenced a tender offer (the "Offer") to purchase for cash any and all of its outstanding euro 300,000,000 principal 9.25% Senior Notes due 2011 (ISIN No. XS0188940505/XS0188941065) (the ...
Pain Management Research Institute
Sydney, Australia, November 28 (ots/PRNewswire) - - Results Offer Hope to Patients With Excruciating Chronic Pain Findings from a new study published today in the journal Neurology demonstrate that the oral medication pregabalin is significantly effective in relieving central neuropathic (nerve) pain and improves pain-related sleep disturbance and anxiety in patients with spinal cord injury. Conducted by ...
Paris, November 22 (ots/PRNewswire) - - New Hope for CML and Ph+ ALL Patients who Face Resistance or Intolerance to Current Therapies For Non-US Journalists Only Today, the European Commission approved SPRYCEL(TM) (dasatinib, formerly known as BMS-354825) for the treatment of adults with chronic, ...
Lakewood, Colarado, November 21 (ots/PRNewswire) - NewWest Gold Corporation (TSX:NWG) ("NewWest" or "the Company") today announced the preliminary results of the 2006 Phase One drilling program at the Northumberland project, located in Nye County, Nevada. These drill results were provided by the Company's joint venture partner, Newmont Mining Corporation ...
. Total Group revenues up to EUR 730 million . Consolidated profit up substantially to EUR 16.9 million . Orders in hand again improved over previous year to EUR 422 million . Positive outlook for the full year 2006 ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Schrobenhausen (euro adhoc) - Schrobenhausen, November 21, 2006 -The construction and ...
Swiftwater, Pennsylvania. and Lyon, France, November 20 (ots/PRNewswire) - - New Pre-Pandemic Vaccine Will Provide Additional Level of Preparedness sanofi pasteur, the vaccines business of the sanofi-aventis Group (NYSE: SNY; EURONEXT: SAN) has signed a contract with the Office of Public Health and ...
Shire Pharmaceuticals Group Plc
Basingstoke, England and San Diego, California, November 20 (ots/PRNewswire) - - Further Data Support the Contribution of FOSRENOL(R) (Lanthanum Carbonate) to the Overall Renal Health of the ESRD Patient While Reducing Mean Phosphate Levels to Within Guideline Targets New data presented on Friday 17th ...
Alliance for Better Bone Health
Paris, November 17 (ots/PRNewswire) - - Actonel Almost Halves the Risk of Breaking a Hip When Compared to Alendronate in the First Year of Treatment - For Non-US Journalists Only Data published today from a retrospective study of over 33,000 postmenopausal women showed that among patients newly ...
Las Vegas, November 15 (ots/PRNewswire) - - New data confirm a five-year risk assessment tool will help ophthalmologists better predict which patients have an increased risk of developing glaucoma - Analysis finds that patients with elevated intraocular pressure (IOP) - along with other ...
Paris, November 9 (ots/PRNewswire) - - Data to be Presented at Upcoming American College of Rheumatology Annual Meeting Bristol-Myers Squibb Company (NYSE: BMY) today announced that two-year data from three Phase III pivotal trials demonstrate the long-term efficacy of abatacept in adult patients with moderate to severe rheumatoid arthritis (RA) who have ...
San Diego, November 2 (ots/PRNewswire) - Fiscal 2006 Revenues US$7.53 Billion, EPS US$1.44 Pro Forma Fiscal 2006 Revenues US$7.53 Billion, EPS US$1.64 Record Fiscal Year Revenues, Net Income and Operating Cash Flows QUALCOMM Incorporated (Nasdaq: QCOM) today announced results for the fourth fiscal quarter and fiscal 2006 year ended September 24, 2006. Total QUALCOMM (GAAP) ...
Basel, Switzerland (ots/PRNewswire) - Seventy percent of European patients battling lung cancer had never regarded the disease as a threat prior to learning of their condition, according to results from a new pan-European public and patient survey announced on the eve of Lung Cancer Awareness Month. This ignorance about lung cancer is also indicative of a chronic ...